Point72 Hong Kong’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,106
| Closed | -$30K | – | 1303 |
|
|
2021
Q4 | $30K | Buy |
+13,106
| New | +$30K | ﹤0.01% | 926 |
|
|
2021
Q3 | – | Sell |
-18,451
| Closed | -$70K | – | 1329 |
|
|
2021
Q2 | $70K | Buy |
18,451
+16,966
| +1,142% | +$64.4K | ﹤0.01% | 840 |
|
|
2021
Q1 | $5K | Sell |
1,485
-3,755
| -72% | -$12.6K | ﹤0.01% | 1134 |
|
|
2020
Q4 | $15K | Buy |
5,240
+3,735
| +248% | +$10.7K | ﹤0.01% | 1007 |
|
|
2020
Q3 | $4K | Buy |
+1,505
| New | +$4K | ﹤0.01% | 1065 |
|
|
2020
Q2 | – | Sell |
-2,009
| Closed | -$15K | – | 1116 |
|
|
2020
Q1 | $15K | Buy |
2,009
+969
| +93% | +$7.24K | 0.01% | 606 |
|
|
2019
Q4 | $7K | Buy |
1,040
+894
| +612% | +$6.02K | ﹤0.01% | 1002 |
|
|
2019
Q3 | $1K | Sell |
146
-2,640
| -95% | -$18.1K | ﹤0.01% | 886 |
|
|
2019
Q2 | $13K | Buy |
+2,786
| New | +$13K | ﹤0.01% | 832 |
|
|
2018
Q3 | – | Sell |
-466
| Closed | -$5K | – | 858 |
|
|
2018
Q2 | $5K | Sell |
466
-4,383
| -90% | -$47K | ﹤0.01% | 699 |
|
|
2018
Q1 | $46K | Buy |
+4,849
| New | +$46K | 0.02% | 468 |
|
|
2017
Q3 | – | Sell |
-3,828
| Closed | -$55K | – | 776 |
|
|
2017
Q2 | $55K | Buy |
+3,828
| New | +$55K | 0.06% | 207 |
|